Dual PPARalpha /gamma activation provides enhanced improvement of insulin sensitivity and glycemic control in ZDF rats.
about
The PPARalpha/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese ratsPersistent organic pollutant exposure leads to insulin resistance syndromeThe power of real-time PCR.Cellular and molecular effects of yeast probiotics on cancer.Platelets as a novel target for PPARgamma ligands : implications for inflammation, diabetes, and cardiovascular disease.Pharmacogenetics of the PPAR genes and cardiovascular disease.Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.Effect of combination treatment of S-amlodipine with peroxisome proliferator-activated receptor agonists on metabolic and cardiovascular parameters in Zucker fa/fa rats.Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.PPARs and nonalcoholic fatty liver disease.The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats.PPARalpha and PPARgamma are co-expressed, functional and show positive interactions in the rat urinary bladder urothelium.Generalized cellular hypertrophy is induced by a dual-acting PPAR agonist in rat urinary bladder urothelium in vivo.Ragaglitazar: the pharmacokinetics, pharmacodynamics, and tolerability of a novel dual PPAR alpha and gamma agonist in healthy subjects and patients with type 2 diabetes.[Future targets in the treatment of type 2 diabetes].Gene expression and adiposity are modified by soy protein in male Zucker diabetic fatty rats.Synergistic effect of the human GLP-1 analogue liraglutide and a dual PPARalpha/gamma agonist on glycaemic control in Zucker diabetic fatty rats.Individual and combined effects of peroxisome proliferator-activated receptor and {gamma} agonists, fenofibrate and rosiglitazone, on biomarkers of lipid and glucose metabolism in healthy nondiabetic volunteers.Combination of the insulin sensitizer, pioglitazone, and the long-acting GLP-1 human analog, liraglutide, exerts potent synergistic glucose-lowering efficacy in severely diabetic ZDF rats.Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo.PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse.Trans-species comparison of PPAR and RXR expression by rat and human urothelial tissues.
P2860
Q28574993-6FB47E80-0646-48FA-92EA-682BD812B024Q33789743-FB4B3E87-943E-447F-A280-3E6616103EC8Q34444172-06361B38-2F45-4733-9AF9-B52B04519515Q36113199-A40A8526-A100-4262-998B-4AA718893830Q36531995-04D5C137-BEFF-4959-B118-84B32AB12DB6Q37012017-C262EAC6-169E-444C-AFE9-2909651B67B6Q37662933-2E249D98-0F85-4D56-9E63-C38C60801998Q37685266-16DA4800-8BDB-4630-B4F8-06A61457F511Q38325827-5EE695A3-52A5-4119-AFEA-CA269A6AF0E0Q39029023-BA562C6E-7F3F-4562-9C5E-8F2B57C04061Q42288257-406E0051-B7B2-466A-B751-BE0AF138C150Q43275962-1ED42D1C-1FFC-426A-B173-9CA4314DD31DQ43461615-8D0B2BC0-EDC7-48B4-A053-CE5AB59AE804Q44613028-B034193B-1812-405E-BF73-2F25F1AB5DE2Q44896352-58A2E00D-E232-4CAF-8039-2BD08A121E8DQ45248677-A4241221-E85E-49EC-8589-A98470D71FC3Q45972805-9678C04F-51FC-4D2D-BD43-BA78FA38FF88Q46438858-9F81BB18-7830-4A06-97D0-5DB91DCD52A9Q46707968-448D46CE-5431-43B1-8628-72E2BD8F91DCQ46766813-F20F21F6-A393-4FD7-9F03-031D842DF694Q50773167-A8826DB3-6963-4BFA-ACC6-3118340A3E27Q53321831-7AE09A69-4879-4385-A396-124D523C4612
P2860
Dual PPARalpha /gamma activation provides enhanced improvement of insulin sensitivity and glycemic control in ZDF rats.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Dual PPARalpha /gamma activati ...... glycemic control in ZDF rats.
@en
Dual PPARalpha /gamma activati ...... glycemic control in ZDF rats.
@nl
type
label
Dual PPARalpha /gamma activati ...... glycemic control in ZDF rats.
@en
Dual PPARalpha /gamma activati ...... glycemic control in ZDF rats.
@nl
prefLabel
Dual PPARalpha /gamma activati ...... glycemic control in ZDF rats.
@en
Dual PPARalpha /gamma activati ...... glycemic control in ZDF rats.
@nl
P2093
P2860
P1476
Dual PPARalpha /gamma activati ...... glycemic control in ZDF rats.
@en
P2093
Birgitte Andersen
Bo F Hansen
Carsten F Gotfredsen
Christian Fledelius
Christian L Brand
Jan Fleckner
Jeppe Sturis
Ji-Ming Ye
Karsten Wassermann
Per Sauerberg
P2860
P304
P356
10.1152/AJPENDO.00348.2002
P577
2002-12-10T00:00:00Z